Perfectly normal practise imo Mr Kanga....Directors are busy looking after different aspects of Bio development & need to meet to catch up on different developments in different areas.Maaan, this ones a loooong time coming......
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025